Skip to main content

Advertisement

Log in

Second meeting of the Spanish Immunotherapy Group GEIT (Grupo Español de Inmunoterapia), January 16, 2015, in Zaragoza, Spain

  • Meeting Report
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abbreviations

Apo2L/TRAIL:

Apo2 ligand/TNF-α-related apoptosis-inducing ligand

CIBA:

Centro de Investigación Biomédica de Aragón (Centre for Biomedical Research of Aragón)

CIMA:

Centro de Investigación Médica Aplicada (Centre for Applied Medical Research)

CNIC:

Centro Nacional de Investigaciones Cardiovasculares (Spanish National Centre for Cardiovascular Research)

CNIO:

Centro Nacional de Investigaciones Oncológicas (Spanish National Centre for Cancer Research)

DNGR-1:

Dendritic cell NK lectin group receptor 1

ESAT-6:

Early secreted antigenic target of 6 kDa

FDA:

Food and Drug Administration

GEIT:

Grupo Español de Inmunoterapia (Spanish Immunotherapy Group)

HBV:

Hepatitis B virus

IIS:

Instituto de Investigación Sanitaria (Institute for Health Research)

MTBVAC:

Mycobacterium tuberculosis vaccine

PD-1:

Programmed death 1

poly I:C:

Polyinosinic: polycytidylic acid

SEI:

Sociedad Española de Inmunología (Spanish Society for Immunology)

Acknowledgments

Bristol-Myers Squibb and Miltenyi Biotec funded this scientific event.

Conflict of interest

The authors declare no conflict of interest. Alberto Anel and Julián Pardo were conference organizers.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alberto Anel.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Anel, A., Martínez-Lostao, L. & Pardo, J. Second meeting of the Spanish Immunotherapy Group GEIT (Grupo Español de Inmunoterapia), January 16, 2015, in Zaragoza, Spain. Cancer Immunol Immunother 64, 1067–1069 (2015). https://doi.org/10.1007/s00262-015-1732-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00262-015-1732-2

Keywords

Navigation